Achieving Long-Term Protection Post-MI: The Accumulated Evidence
Provided By: Medscape
How likely are you to recommend My CE to a friend?
Thank you for your feedback!
Tell us more about your experience
To improve search results, tell us about yourself!
To improve search results, tell us about yourself!
To improve search results, tell us about yourself!
To improve search results, tell us about yourself!
To improve search results, tell us about yourself!
To improve search results, tell us about yourself!
To improve search results, tell us about yourself!
Hide
Free
Join Drs. Steg, Mehran, Stone, and Valgimigli for a case-based discussion on long-term secondary prevention post-ACS.
This activity is intended for cardiologists, primary care physicians, and emergency medicine physicians.
The goal of this activity is to review the evidence and guidelines informing the optimal length of dual antiplatelet therapy post-ACS.
Expiration Date
June 20, 2017
Location:
Online
0.5 Credits
What Will I Learn?
Upon completion of this activity, participants will be able to:
1. Summarize clinical data on the use of antiplatelet therapy for secondary prevention in patients post-acute coronary syndrome (ACS)
2. Identify patients who may benefit from extended antiplatelet therapy
3. Explore individualized treatment plans for secondary prevention post-ACS
1. Summarize clinical data on the use of antiplatelet therapy for secondary prevention in patients post-acute coronary syndrome (ACS)
2. Identify patients who may benefit from extended antiplatelet therapy
3. Explore individualized treatment plans for secondary prevention post-ACS
Website
Pricing
Free
Format
Online Article
Ideal Audience
- Ideal Audience includes: MD and Cardiology, Emergency Medicine
- The Accredited Provider is: Medscape
Publication of activity information does not imply endorsement by or affiliation with the CE App or ACEA. All activity names, trademarks, and brands are the property of their respective owners. Information is not guaranteed to be accurate. Please refer to original sources for the most up-to-date information.
Share This CE
Email this CE to a friend.
Email Support
We'll get back to you very soon!